We subsequently demonstrated a similar requirement for NUAK1 to facilitate the NRF2‐dependent adaptation to oxidative stress in colorectal cancer, resulting in a targetable requirement for NUAK1 to maintain colonic tumours driven by loss of Apc and activating mutation of KRas, which converge to increase MYC expression [9]. This evidence concerns the gene NUAK1 and colorectal cancer.